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It has been earlier proposed that oxytocin could play a facili-
tatory role in the preovulatory LH surge in both rats and
humans. We here provide evidence that oxytocin also facili-
tates sexual maturation in female rats. The administration of
an oxytocin antagonist for 6 d to immature female rats de-
creased GnRH pulse frequency ex vivo and delayed the age at
vaginal opening and first estrus. The in vitro reduction in
GnRH pulse frequency required chronic blockade of oxytocin
receptors, because it was not acutely observed after a single
injection of the antagonist. Hypothalamic explants exposed to
the antagonist in vitro showed a reduced GnRH pulse fre-
quency and failed to respond to oxytocin with GnRH release.
Prostaglandin E2 (PGE2) mimicked the stimulatory effect of
oxytocin on GnRH pulse frequency, and inhibition of PG syn-
thesis blocked the effect of oxytocin, suggesting that oxytocin
accelerates pulsatile GnRH release via PGE2. The source of
PGE2 appears to be astrocytes, because oxytocin stimulates
PGE2 release from cultured hypothalamic astrocytes. More-
over, astrocytes express oxytocin receptors, whereas GnRH
neurons do not. These results suggest that oxytocin facilitates
female sexual development and that this effect is mediated by
a mechanism involving glial production of PGE2. (Endocri-
nology 149: 1358–1365, 2008)
OXYTOCIN PLAYS a crucial role in reproduction. Thepeptide plays a pivotal role in parturition and lacta-
tion in many species (1) and acts centrally to influence ma-
ternal and mating behavior in rodents (2–4). In addition to
this involvement in reproductive behavior, oxytocin has
been shown to stimulate GnRH secretion from medial basal
hypothalamic explants of adult male rats (5) and of cycling
female rats on the afternoon of proestrus (6). Using hypo-
thalamic explants from male rats, one of our laboratories
recently showed that neonatal pulsatile GnRH secretion in
vitro is facilitated by oxytocin and that this stimulatory effect
is mimicked by prostaglandin E2 (PGE2) (7).
Sexual maturation involves an acceleration of pulsatile
GnRH secretion (8–10). This activation is elicited by neuronal
as well as astroglial factors produced by cells functionally
connected to GnRH neurons (11). The neuronal networks
involved in the transsynaptic regulation of GnRH secretion
mainly comprise neurons that use excitatory and inhibitory
amino acids for neurotransmission in addition to the newly
discovered kisspeptin-GPR54 signaling system (12, 13).
However, additional neuronal systems that either stimulate
or inhibit GnRH secretion have been described, including
noradrenergic, dopaminergic, and opiatergic neurons (14).
More recently, oxytocin neurons have been involved in the
facilitatory control of GnRH secretion (5–7). The recent find-
ings that oxytocin stimulates GnRH secretion in prepubertal
male rats (7) and that administration of an oxytocin antag-
onist blunted the preovulatory LH peak in women (15)
prompted us to study the role of oxytocin in female puberty.
Thus, we aimed at studying in vivo the possible delaying
effects of an oxytocin antagonist on female sexualmaturation
and used an explant paradigm to define in vitro the mech-
anism underlying this effect. In particular, we aimed at de-
termining whether PGE2 mediates the facilitatory effect of
oxytocin on pulsatile GnRH secretion, a pathway suggested
by the ability of oxytocin to stimulate PGE2 release from the
rat hypothalamus (5), and the effectiveness of PGE2 to stim-




Female Wistar rats used for in vivo studies and in vitro experiments
to measure pulsatile GnRH release were housed in temperature- and
light-controlled conditions andwere given ad libitum access towater and
standard rat pellets. The prepubertal animals were housed with their
mothers until weaning at 3 wk of age. Except on d 1when rats were used
irrespective of gender, only female rats were used. The day of birth was
considered as postnatal d 1. Two-day-old female rats of the Sprague
Dawley strain purchased from Charles River Laboratories (Wilmington,
MA) were used for RNA extraction and preparation of astrocyte cul-
tures. For comparative purposes, RNA was also extracted from the
hypothalamus of 2-d-old femalemice (FVB/NTAC strain; Taconic,Hud-
son, NY). The use of rats and mice was approved by the University of
Liege and the Oregon National Primate Research Center Animal Care
andUseCommittees in accordancewith theNational Institutes ofHealth
guidelines for the use of animals in research.
Incubation of hypothalamic explants and GnRH RIA
The animals were decapitated between 1000 and 1100 h, and tissue
fragments that included the preoptic region and the medial basal hy-
pothalamus were rapidly dissected and transferred into a static incu-
bator. In each experiment, 12–15 explants were studied individually for
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4–6 h through collection and renewal of the incubationmedium (0.5 ml)
every 7.5 min. This procedure has been described in detail in previous
publications (7, 10, 18). The incubation medium was phenol red-free
MEM (Life Technologies, Inc., Invitrogen Corp., Merelbeke, Belgium)
supplementedwith glycine (10 nm), magnesium (1mm), and glucose (25
mm). The incubation mediumwas supplemented with 20 m bacitracin,
an inhibitor of GnRH degradation by endopeptidases. The medium
samples were frozen until the GnRH RIA was performed. GnRH was
measured in duplicate samples using a highly sensitive RIA (18, 19) and
an antiserum (20) generously provided by Dr. Y. F. Chen and V. D.
Ramirez (Urbana, IL). The intra- and interassay coefficients of variation
were 14 and 18%, respectively (18, 19). Values below the limit of de-
tection of the assay (5 pg/7.5 min) were assigned that value.
Cell culture
Astrocytes were isolated from the hypothalamus of 1- to 2-d-old rats
and cultured as described previously (21, 22). After a growth period of
8–10 d in 75-cm3 culture flasks containing DMEM-F12 medium sup-
plemented with 10% calf serum, the astrocytes were isolated from con-
taminant cells by overnight shaking at 250 rpm and were replated on
10-cm3 dishes for RT-PCR or 12-well plates for PGE2 release experi-
ments. After reaching 90% confluence, the medium was replaced with
a serum-free, astrocyte-defined medium consisting of DMEM devoid of
phenol red, supplemented with 2 mm l-glutamine, 15 mm HEPES, 5
g/ml insulin, and 100 m putrescine. The cells were used 2 d later for
RT-PCR or PGE2 release experiments. For RT-PCR, the cells were snap-
frozen on dry ice before extraction of total RNA. To assess the effect of
oxytocin on PGE2 release, the cells were incubated for 16 hwith oxytocin
acetate (108 m; Sigma Chemical Co., St. Louis, MO). TGF (100 ng/ml;
PreproTech Inc., Rocky Hill, NJ) was used as a positive control. After
stimulation, the mediumwas collected and stored at85 C before PGE2
assay.
The immortalized GnRH-producing cells GT1-7 (kindly provided by
Dr. R. Weiner, University of California, San Francisco, CA) were cul-
tured in 10-cm dishes in DMEM containing 10% fetal calf serum. After
reaching 70–80% confluence, the cells werewashedwith PBS and frozen
on dry ice before RNA extraction.
Measurement of PGE2 release
PGE2 released from astrocytes in response to TGF or oxytocin was
measured by RIA as described previously (23).
RNA extraction and RT-PCR
Total RNA from rat andmouse hypothalamiwas prepared by the acid
phenol-extraction method. Tissues were homogenized (100 mg/ml) in
Tri Reagent (Molecular Research Center, Cincinnati, OH), and the aque-
ous and organic phases were separated by the addition of 0.1 vol bro-
mochloropropane (Sigma) followed by centrifugation at 4 C. One vol-
ume of isopropanol was added to the aqueous phase, and RNA was
precipitated by overnight incubation at 20 C. Samples were centrifu-
gated at 14,500  g for 15 min at 4 C. The pellets were washed in 70%
ethanol and then air dried for 5 min. The RNA pellets were then re-
suspended in diethylpyrocarbonate-treated H2O, and the suspension
was incubated with DNA-free DNase I (two units per reaction) from
Ambion (Austin, TX) for 30 min at 37 C. RNA concentrations were
determined spectrophotometrically, and RNA integrity was verified on
denaturing agarose gels.
RT2-PCRwasused to detect oxytocin receptor (OTR)mRNA in cultured
hypothalamic astrocytes, GT1-7 cells, and hypothalami obtained from 2-d-
old female rats and mice. Five hundred nanograms of total RNA were
reverse transcribed using Omniscript RT Kit (QIAGEN, Valencia, CA)
according to the manufacturer’s instructions. PCR was performed in a
volume of 25 l containing 1 l RT product, 2.5 l 10 buffer (HotStar Taq
PolymeraseKit;QIAGEN), 1l 10mmdNTPs (HotStarTaqPolymeraseKit;
QIAGEN), 0.15 l HotSar Taq Polymerase (QIAGEN), and 0.5 l OTR
primers (50m) or 0.5l of a set of primers (50m) that amplify cyclophilin
mRNA, a constitutively expressed mRNA. After an initial incubation at 95
C for 15 min, the samples were amplified for 35 cycles consisting of 30 sec
at 94C (denaturing), 30 sec at 64C (annealing), and1minat 72C (extension)
and then incubated 10 min at 72 C (final extension). The primers were
designed using the Primer Select software (DNASTAR Inc., Madison, WI)
andwere as follows: mouse OTR (XM_144956.6) sense 5-TTCTACGGGC-
CCGACCTGCTGTGT-3 and antisense 5-CTGTGCGGATTTTGGCCTT-
GGAGA-3, rat OTR (NM_012871.2) sense 5-TTCTATGGGCCCGACCT-
GCTGTGT-3 and antisense 5-CCGTGCGGATTTTGGCCTTGGAGA-3,
mouse cyclophilin (NM_008907) sense 5-GGCAAATGCTGGACCAAA-
CACAA-3 and antisense 5-GGTAAAATGCCCGCAAGTCAAAAG-3,
and rat cyclophilin (M19533) sense 5-CTTTGCAGACGCCGCTGTCT-
CTTTTCGCCG-3 and antisense 5-GCATTTGCCATGGACAAGATGC-
CAGGA-3. PCR products were resolved on a 2% agarose gels and
visualized by ethidium bromide staining. Both rat and mouse OTR
primers amplify a 505-bp PCR product.
Combined immunohistochemistry-in situ hybridization
To determine whether OTR mRNA is expressed in GnRH neurons of
the rat hypothalamus, we used a combined immunohistochemistry-in
situ hybridization procedure described earlier in detail (17, 24). GnRH
neurons were stained with a monoclonal antibody to GnRH (25) diluted
1:3000, and the reaction was developed to a brown color with 3,3-
diaminobenzidine. After completing the GnRH immunohistochemical
procedure, the sections were mounted on glass slides and dried over-
night under vacuum before hybridization with a [35S]UTP-labeled rat
(r)OTR cRNA probe described below. After an overnight hybridization
at 55 C, the slides were washed and processed for cRNA detection. After
a final dehydration step in graded alcohols, the slides were dipped in
NTB-2 emulsion and were exposed to the emulsion for 3 wk at 4 C. At
this time, the slides were developed, counterstained with 0.1% methyl
green, quickly dehydrated, dried, and coverslipped for microscopic
examination. All reagents used for the immunohistochemical procedure
were prepared in diethylpyrocarbonate-treated water.
The OTR cRNA probe used was prepared by in vitro transcription of
a cDNA template cloned into the pGEM-T vector (Promega, Madison,
WI) and that derived from the 505-bp PCR product described above.
Study protocols
Effect of an oxytocin antagonist on sexual maturation. From d 15–20 of age,
16 immature female rats received a daily ip injection of 200 g/kg of an
oxytocin antagonist, des-Gly-NH2d(CH2)2[d-Tyr
2, Thr4]vasotocin (107
m), generously provided by Dr. Maurice Manning, Medical University
ofOhio, Toledo,OH. This antagonist is selective for theOTRwith respect
to vasopressin receptors, in particular the closely related vasopressin
receptor V1a (26). Such selectivity allowed us to consider the effect of the
antagonist as specifically due to functional disruption of the intended
target.
The antagonist was diluted in saline. The control group consisted of
16 immature female rats receiving an ip injection of the saline vehicle
from d 15–20 at 0800 h. On d 20, 2 h after the last injection, eight of the
oxytocin antagonist-treated rats and eight of the control rats were killed,
and the hypothalamus was dissected and incubated for 4 h either in
regular medium or in the presence of oxytocin (108 m). The other half
of the control and oxytocin antagonist-treated groups were inspected
daily from d 20 on for vaginal opening. Subsequently, vaginal lavages
were obtained daily for 6 wk to determine the age at first estrus (27), and
the cells were visualized after staining using the Papanicolaou method.
The second experiment followed the same protocol, except that the
rats were injected daily between d 10 and 20 of age to determinewhether
an earlier neutralization of oxytocin actions was more effective to delay
sexual maturation.
To determine whether the effect of the oxytocin antagonist admin-
istration in vivo on GnRH pulse frequency in vitro resulted from an acute
effect of the last dose injected or a chronic effect of the 6-d treatment, a
group of 16 20-d-old female rats received only one injection of oxytocin
antagonist or saline at 0800 h and were killed 2 h later. The hypothalami
were dissected and incubated as above.
Dose dependency of oxytocin stimulatory effect on pulsatile GnRH secretion in
vitro. Because the above in vitro paradigm allowed us earlier to detect an
increase in frequency of pulsatile GnRH secretion between 10 and 25 d
of age inmale rats (8), the present studieswere performedusing explants
of an intermediate age (15 d). Pulsatile GnRH secretion was evaluated
after exposing the explants to 1010, 109, 108, or 107 m oxytocin for
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4 h (four explants per concentration) in comparison with eight explants
incubated under control conditions.
Effect of oxytocin on GnRH pulse frequency in vitro. Pulsatile GnRH secre-
tion was studied for 4 h, starting at 1000 h, using explants obtained from
1-, 5-, 15-, and 50-d-old female rats. The 50-d-old rats were used irre-
spective of the phase of the estrous cycle. In a previous study,we showed
that changes in pulsatile GnRH secretion related to the phase of the
estrous cycle were detected only when the experiments were started
around 1600 h (28). The explants were incubated with saline vehicle,
oxytocin alone, or a combination of oxytocin and the oxytocin antagonist
(n  5 for each condition), as outlined above.
Oxytocin-PGE2 interactions in vitro. Pulsatile GnRH secretionwas studied
for 4 husing explants obtained from1- and 15-d-old female rats. Pulsatile
GnRH secretion was studied under control conditions, in the presence
of oxytocin (108 m) or PGE2 (10
6 m) or in the presence of arachido-
nylfluoromethyl ketone (AACOCF3, 25 m; Biomol Research Labora-
tories, Plymouth Meeting, PA), a blocker of phospholipase A2 (PLA2)
that results in inhibition of PGE2 synthesis. This inhibitorwas used alone
or together with oxytocin (108 m).
Statistical analysis
Pulses of GnRH secretion were identified using the Pulsar program,
as described previously (29). The individual interpulse interval as well
as the mean  sem interpulse interval was calculated. In several in-
stances, all the interpulse intervals were equal, thus accounting for an
sem equal to zero.
The effect of the different agents on GnRH pulse amplitude and
frequency was analyzed by one-way ANOVA followed by the Student-
Newman-Keuls test. The effect of the oxytocin antagonist on the age at
vaginal opening and first estrus was analyzed by unpaired t test. The
threshold for significant difference was P  0.05.
Results
Effect of an oxytocin antagonist on female sexual
maturation
In rats treatedwith an oxytocin antagonist for 6 d (d 15–20),
vaginal opening was delayed compared with rats injected
with the vehicle (35 0 vs. 33 0 d, P 0.0001; Fig. 1A). The
age at first estrus, which defines the age of first ovulation,
was not affected (Fig. 1B). When treatment with the oxytocin
antagonist started earlier (d 10 instead of 15), both vaginal
opening and the age at first estrus were significantly delayed
(P  0.0001; Fig. 1, C and D).
In vitro study of GnRH pulse frequency under control
conditions using hypothalamic explants from female rats at
5, 10, 15, 20, 25, and 30 d of age showed a decrease of GnRH
interpulse interval between d 10 and 20 (Fig. 1E). When the
hypothalamic explants of the rats treated in vivo with the
oxytocin antagonist were studied in vitro on d 20, the GnRH
interpulse interval was significantly increased with respect
to explants obtained from vehicle-treated animals (51 3 vs.
44 3 min, respectively, P 0.001; Figs. 1E and 2, A and B).
This increase resulted from the chronic administration of the
FIG. 1. Effect of in vivo administration of an oxytocin antagonist on
the onset of puberty in female rats and on pulsatile hypothalamic
GnRH release. A, Age at vaginal opening in vehicle-treated rats and
rats treated with an oxytocin antagonist from postnatal d 15–20. B,
Age at first estrus of the same animals. Bars are means, and vertical
lines are SEM. Each group represents themean of seven to 10 animals.
C, Age at vaginal opening in female rats treated with the oxytocin
antagonist or vehicle from postnatal d 10–20. D, Age at first estrus
of the same animals. Bars are means, and vertical lines are SEM. Each
group represents the mean of seven to 10 animals. E, GnRH inter-
pulse interval during female rat development using hypothalamic
explants from 5-, 10-, 15-, 20-, 25-, and 30-d-old rats as well as hy-
pothalamic explants of 20-d-old rats incubated in vitro after a 6-d
treatment (d 15–20) with an oxytocin antagonist. Bars represent the
mean  SEM of four to five explants for each age. *, P  0.001 vs.
vehicle-treated group; &&, P  0.001 vs. preceding age; &, P  0.05
vs. preceding age.
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antagonist because the GnRH interpulse interval was not
affected by a single in vivo administration of the antagonist
on d 20 (45  0 min; Fig. 2C). Exposure of the explants from
rats injected with the vehicle to oxytocin in vitro resulted in
a significant reduction in GnRH interpulse interval (40  4
vs. 44 3 min, P 0.01; Fig. 2, A and D). This was consistent
with our previous data showing a facilitatory effect of oxy-
tocin on pulsatile GnRH secretion from male hypothalami
(7). Administration of the oxytocin antagonist for 5 d in vivo
did not affect this in vitro effect of oxytocin (48  4 vs. 51 
3 min, P  0.05; Fig. 2, B and E), likely due to displacement
of decreasing antagonist concentrations by an excess of oxy-
tocin from common binding sites.
Dose dependency and ontogeny of oxytocin and oxytocin
antagonist effect on pulsatile GnRH secretion in vitro
Incubation of hypothalamic explants from 15-d-old female
rats with oxytocin resulted in a dose-dependent reduction in
GnRH interpulse interval, which was significant at concen-
trations of 109 to 107 m (Fig. 3). When explants from 1-, 5-,
and 15-d-old rats were examined, themeanGnRH interpulse
interval was significantly (P  0.001) reduced by incubation
with 108m oxytocin (Fig. 4). Conversely, with the exception
of d 5, GnRH pulse frequency was significantly decreased by
addition of the oxytocin antagonist to the incubation me-
dium, in the absence of exogenous oxytocin. This effect is
consistent with previous results obtained using explants
from male rats (7). Control hypothalami showed a GnRH
interpulse interval that decreased gradually throughout sex-
ual maturation, reaching minimal values at 50 d of age (Fig.
4). At this time, neither oxytocin nor the antagonist was any
longer effective in altering pulsatile GnRH release. When
explants from 5-d-old rats were incubated simultaneously
with oxytocin and its antagonist, the effect of oxytocin on
GnRH interpulse interval was totally inhibited (Fig. 4).
Oxytocin-PGE2 interactions in vitro
Because oxytocin has been shown to induce PGE2 release
from medial basal hypothalamic explants (5), we hypothe-
sized that PGE2 might mediate the stimulatory effect of oxy-
tocin on pulsatile GnRH secretion. As shown in Fig. 5, both
oxytocin and PGE2 were able to significantly decrease GnRH
interpulse interval at the two ages studied (1 and 15 d).
AACOCF3, an inhibitor of PLA2, wasmore effective in block-
ing the effect of oxytocin on d 1 than on d 15. When used
alone AACOCF3 had no effect.
Study of OTR expression in GnRH neurons
The actions of oxytocin are mediated by activation of G
protein-coupled receptors (30). To determinewhether GnRH
neurons express the OTR gene, we examined the preoptic
region of two immature 28-d-old female rats. GnRH neurons
were identified by immunohistochemistry and OTR mRNA
by in situ hybridization. In agreement with earlier findings
(31), OTR transcripts were expressed at low abundance in
cells scattered throughout the suprachiasmatic region. How-
ever, they were not detected in GnRH neurons. Instead,
FIG. 4. Effect of an oxytocin antagonist on GnRH interpulse interval
and on the increase in GnRH pulse frequency elicited by oxytocin
during postnatal development of the female rat hypothalamus. Hy-
pothalamic explants from1-, 5-, 15-, and 50-d-old ratswere used.Bars
represent means (n  4), and vertical lines are SEM. A group of hy-
pothalamic explants from 5-d-old rats was incubated in presence of
both oxytocin and oxytocin antagonist. *, P  0.001 vs. group incu-
bated with vehicle alone; §, P 0.001 vs. group treated with oxytocin
alone.
FIG. 2. Representative profiles of GnRH secretion from hypotha-
lamic explants of 20-d-old female rats. The rats received a daily
injection of vehicle (A and D) or 200 g/kg of an oxytocin antagonist
(B and E) from d 15–20 or only one injection of oxytocin antagonist on
d 20 (C). The explants were incubated with 108 M oxytocin (D and E)
or without the hormone (A–C). Each group consists of five explants.
FIG. 3. Effects of increasing oxytocin concentrations on the GnRH
interpulse interval (mean  SEM) of hypothalamic explants from 15-
d-old female rats (n  4 explants per group). NS, Not significantly
different from vehicle-treated group.
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hybridization signals were seen in cells adjacent (Fig. 6, A
and B) or near (Fig. 6C) these neurons.
Study of OTR mRNA in hypothalamic astrocytes and
GT1-7 cells
Detection of OTR mRNA by RT-PCR showed that the
transcripts are abundant in cultured rat hypothalamic astro-
cytes and in the rat medial basal hypothalamus (Fig. 7A). In
contrast, they were absent in immortalized mouse GnRH
neurons but clearly evident in cultured mouse hypothalamic
astrocytes and mouse medial basal hypothalamus (Fig. 7B),
suggesting that oxytocin might act on astrocytes to stimulate
GnRH release indirectly, instead of acting onGnRHneurons.
PGE2 release by oxytocin from hypothalamic astrocytes
TGF stimulates GnRH release via a glial intermediacy
that involves activation of astrocytic erbB1 receptors and the
subsequent release of PGE2 (32). We hypothesized that oxy-
tocin action on GnRH neurons could be similarly mediated
by astrocytic PGE2. We measured PGE2 release from rat
hypothalamic astrocytes in primary culture after 16 h of
exposure to oxytocin (108 m) or TGF (100 ng/ml). As
shown in Fig. 7C, oxytocin induced a significant (P  0.01)
increase in PGE2 release, which was, however, lower than
that elicited by TGF.
Discussion
In this paper, we provide evidence that oxytocin facilitates
sexual maturation in the female rat. We also show that oxy-
tocin accelerates GnRH pulse frequency in vitro from hypo-
thalamic explants obtained from female rats of different pre-
pubertal ages and that this effect is mostly lost in adulthood.
Using medial basal hypothalamic explants obtained from
adult male rats, acceleration of GnRH pulsatile release by
oxytocin concentrations as low as 1010 m was previously
FIG. 5. Effects of PGE2 on GnRH pulse frequency and of an inhibitor
of PLA2 synthesis (AACOCF3) on the increase in GnRH pulse fre-
quency elicited by oxytocin on hypothalamic explants from 1- and
15-d-old female rats (n  4 per group). Bars are means, and vertical
lines represent SEM. *, P  0.001 vs. control group incubated with
vehicle; §, P  0.001 vs. group treated with oxytocin.
FIG. 6. Absence of OTR mRNA in GnRH neurons of the immature
(28-d-old) female rat preoptic region, as assessed by combined im-
munohistochemistry (GnRH)/in situ hybridization (OTR) using a
[35S]UTP-labeled OTR cRNA. A and B, Examples of OTR mRNA-
positive cells (arrows) adjacent to GnRH neurons (brown staining)
lacking detectable OTR mRNA transcripts. C, OTR mRNA-positive
cells (arrows) in the vicinity of GnRH neurons lacking OTR mRNA.
Bars, 20 m.
FIG. 7. OTR mRNA can be detected by RT-PCR in hypothalamic
astrocytes but not in immortalized GnRH-producing cells. A, OTR
mRNA is present in cultured rat hypothalamic astrocytes (Astr-1 and
Astr-2) and ratmedial basal hypothalamus (MBH).B,Absence ofOTR
mRNA in GT1-7 cells (GT), in contrast with its presence in both
cultured mouse hypothalamic astrocytes (Astr) and mouse MBH. C,
Stimulation of PGE2 release from rat hypothalamic astrocyte cultures
by oxytocin (108 M) or TGF (100 ng/ml). Bars are means, and
vertical lines are SEM.Numbers in parentheses are number of wells per
group. **, P  0.01; *, P  0.05 vs. basal release. Cyclo, Cyclophilin
mRNA; MM, molecular markers; RT, no RT reaction.
1362 Endocrinology, March 2008, 149(3):1358–1365 Parent et al. • Oxytocin and Female Sexual Maturation
 by Jean Bourguignon on June 2, 2008 endo.endojournals.orgDownloaded from 
reported (5). The present study, using hypothalamic explants
from female rats, is in agreement with those earlier findings.
That endogenous oxytocin is physiologically involved in
the control of female puberty is suggested by the delayed
sexual maturation resulting from blocking oxytocin actions
during the infantile period of postnatal development. Of
note, the oxytocin antagonist did not affect pulsatile GnRH
secretion from 5-d-old explants, in contrast to the inhibitory
effects observed earlier on d 1 and later on d 15. This inef-
fectiveness at 5 d may be related to a low availability of
endogenous oxytocin at this age, instead of a reduced OTR
response, because oxytocin was as effective on d 5 as on d 1
or 15 to increase GnRH pulse frequency. It is possible that
after the effect of oxytocin of maternal origin dissipates
shortly after birth, a maturational process is required for
endogenous oxytocin to be released at physiologically rele-
vant amounts in the offspring. Earlier studies have shown
that significant amounts of mature oxytocin are detected in
the hypothalamus only after the secondweek of postnatal life
(33, 34). In agreement with this hypothesis, a study reported
the absence of effect of the oxytocin antagonist on age at
vaginal opening and first estrus when administered between
1 and 7 d of age. In contrast, they observed a delayed vaginal
opening and first estrus after exposure to oxytocin during the
same period (35). Our in vitro data suggest that the stimu-
latory effect of oxytocin on GnRH secretion decreases with
age. This could be due to an age-related increase in oxytocin
clearance or a reduced activity of its receptor. No study has
specifically reported the ontogeny of oxytocin expression in
the rat hypothalamus during pubertal maturation. However,
Chibbar et al. (36) have shown that oxytocin mRNA levels
increase in rats after puberty, after sex steroids stimulation.
The regulation of the OTR appears to be complex as well.
Although the receptor is expressed prenatally in the rat brain
(37), the same study described a progressive decrease in
receptor expression in certain regions, such as the hippocam-
pus and the parietal cortex during postnatal development
(37). Autoradiography experiments have shown the appear-
ance of OTRs in the rat ventromedial hypothalamus at the
time of puberty, probably under the stimulation of estrogens
(38). To our knowledge, expression of the OTR in the hypo-
thalamus during pubertal development has never been stud-
ied. The age-related decrease in oxytocin effectiveness in our
model might be related to a decrease in expression of its
receptor, as suggested by the aforementioned studies. Al-
ternatively, a change in receptor affinity for oxytocin may
also occur as the animal matures. However, only a limited
subset of oxytocin neurons project to targets located within
the hypothalamus (39). Thus, changes of oxytocin expression
affecting the overall population of oxytocin neurons might
make it difficult to identify changes occurring only in those
subsets of oxytocin neurons innervating the hypothalamus.
Beside its role in puberty, oxytocin has been suggested to
play a role in the preovulatory LH surge. Using explants
obtained at different phases of the estrous cycle, it has been
shown that oxytocin can stimulate GnRH release in the af-
ternoon of proestrus only (6). In our study, neither oxytocin
nor the antagonist was any longer effective in significantly
altering the frequency of pulsatile GnRH secretion in adult
female rats. However, these data were obtained using ex-
plants studied in the morning, whereas we have shown ear-
lier that the amplitude of GnRH secretion was increased in
the afternoon of proestrus (28). Data concerning oxytocin
effects on the human menstrual cycle are controversial. In
contrast to the data showing an effect of oxytocin and an
oxytocin antagonist on the endogenous LH surge (15, 40), a
recent study showed that neither oxytocin nor its antagonist
had any effect on basal and GnRH-induced gonadotropin
secretion in the late follicular phase of the normal menstrual
cycle (41).
A major finding of the present study is that blockade of
endogenous oxytocin actions by in vivo administration of a
specific antagonist delays the initiation of female puberty.
The onset of puberty is characterized by an increase in GnRH
pulse generator activity (7). The main hypothalamic neuro-
transmitters/neuromodulators involved in this activation
have been extensively characterized (14). They include ex-
citatory and inhibitory amino acids such as -aminobutyric
acid and glutamate (11) and the newly described neuropep-
tide kisspeptin (12, 13). Our results suggest the existence of
an independent oxytocin-mediated pathway contributing to
the central regulation of the pubertal process. When endog-
enous oxytocin actions are blocked transiently (single injec-
tion of the antagonist), the timing of puberty is not affected.
A delay is observed only when the antagonist is given for 6 d
at the end of the infantile period, and becomes more evident
when the treatment is initiated at an even earlier age. The age
at which the antagonist is effective and the need for a sus-
tained blockade for the antagonist to act effectively suggests
that oxytocin regulates the pubertal process by modifying
hardwiring events that take place during infantile develop-
ment. The nature of these events has not been elucidated, but
it may be related to the ability of oxytocin to cause morpho-
logical changes in glial cells and neurons (42). Other studies
have shown that both neuronal remodeling induced by oxy-
tocin (43) and permanent sex-related changes in glial mor-
phology that occur during early postnatal development are
mediated by PGE2 (44). Thus, our in vivo and in vitro data
suggest the convergence of different regulatorymechanisms.
The stimulatory effect of oxytocin on PGE2 release from
astrocytes in primary culture as well as the stimulatory effect
of oxytocin on GnRH secretion from hypothalamic explants
in vitro suggest a rapid stimulatory effect of oxytocin. Oxy-
tocin stimulation leads to a release of PGE2 that is able to
directly stimulate GnRH release (17). The necessity of re-
peated in vivo injections suggests a long-term effect poten-
tially involving morphological changes, as discussed above.
The oxytocin antagonist was administered by ip injection,
leading to the question of its transfer across the blood-brain
barrier. The common understanding is that oxytocin antag-
onists cross the blood-brain barrier in small amounts (45–47).
However, oxytocin antagonists have been shown to induce
behavioral changes when administered peripherally, imply-
ing a rate of brain transfer sufficient to induce central effects
(48–50). Because these behavioral effects were observed
shortly after a single peripheral injection of the oxytocin
antagonist (50), it would appear unlikely that the antagonist
failed to cross the blood-brain barrier in our experiments. In
the present study, the concordant reduction in GnRH pulse
frequency observed both ex vivo after systemic administra-
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tion of the antagonist and in vitro demonstrates that the
antagonist is acting centrally after peripheral administration.
However, a peripheral effect of the injected oxytocin antag-
onist cannot be excluded. Oxytocin and its receptor are both
expressed in rodent, human. and nonhuman primate ovaries
(51–53), and the local production of oxytocin seems to play
a role in the regulation of ovarian function during the estrous
cycle (reviewed in Ref. 54). To our knowledge, no effect of
oxytocin on ovarian maturation has been yet shown.
Oxytocin neurons are located in the supraoptic and the
paraventricular nuclei, and their axons terminate in several
areas including the median eminence and the rostral hypo-
thalamus (39). Our results suggest that oxytocin does not
stimulate pulsatile GnRH release by acting directly onGnRH
neurons. Instead, the stimulatory effect of oxytocin on GnRH
secretion appears to be mediated by PGE2 released from
astrocytes. These findings are in keeping with earlier reports
showing the involvement of PGE2 in mediating oxytocin
actions in other cellular systems (55). PGE2 is a potent GnRH
secretagogue (16), which upon release from glial cells, binds
to specific receptors located onGnRHneurons to elicit GnRH
release (17) (reviewed in Ref. 56) However, a very recent
study using double-label immunofluorescence reported the
expression of OTR in 10% of the GnRH neurons in female rat
hypothalamus (57), suggesting a possible direct action of
oxytocin on GnRH neurons. Our results did not reveal the
presence of OTR mRNA in GnRH neurons. Our combined
immunohistochemistry/in situ hybridization procedure
might not be sensitive enough to detect low levels of tran-
scripts in such a small fraction of neurons.
Cytosolic PLA2 is a major enzyme involved in prostaglan-
din production by generating arachidonic acid, the precursor
of the prostaglandins, from membrane glycerophospholip-
ids. Blocking PLA2 with AACOCF3 prevented the effect of
oxytocin on GnRH pulse frequency, implicating prostaglan-
dins in this process. That the prostaglandin involved is PGE2
of glial origin was evidenced by the presence of OTRs in
astrocytes but not GnRH neurons and the ability of hypo-
thalamic astrocytes to release PGE2 in response to oxytocin.
Because the effect of oxytocin was more evident after 16 h,
it is possible that the effect of oxytocin on PGE2 release may
involve an increase of cyclooxygenase 2 expression, because
it is observed in supraoptic neurons and astrocytes (43).
Although the stimulatory effect of PGE2 on GnRH release
appears to be more prominent in the median eminence (16),
the main terminal field for GnRH axons, PGE2 is also able to
stimulate GnRH neurons when directly applied to the pre-
optic region (58). That this is an important site of action in
mediating oxytocin-induced GnRH release is suggested by
the previous observation that during the preovulatoryGnRH
release, a stimulatory effect of oxytocin requires the presence
of the preoptic area in addition to the median eminence (6).
Spontaneousmutations in the oxytocin gene have not been
reported in either rodents or humans. With the exception of
an inability to eject milk, no reproductive defects have been
reported to occur in oxytocin knockout mice (59). Because it
frequently occurs when describing knockout animals, a de-
tailed analysis of potential defects in pubertal maturation
resulting from oxytocin deficiency has not been undertaken,
but is necessary. Given the complexity of the neuroendocrine
mechanisms involved in controlling puberty, the failure of
unconditional gene targeting to verify findings made via
other means can be best explained as due to early compen-
satory mechanisms set in motion in response to the gene
deletion.
In summary, our results show that oxytocin can act on the
immature female hypothalamus to accelerate pulsatile
GnRH release and to advance the onset of female puberty.
Our results also show that this effect requires the interme-
diacy of OTR-containing astroglial cells that respond to oxy-
tocin with PGE2 release.
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